Kaiser Family Foundation. Copyright 2009 Advisory Board Business and Kaiser Family Foundation. All rights reserved.. AFP examines latest HIV vaccine findings Agence France-Presse examines how two recent research have ‘boosted morale’ among HIV vaccine researchers who have struggled for decades to develop a viable vaccine to safeguard folks from the virus. ‘On September 3, experts in the United States discovered two powerful antibodies – – the frontline troops in the disease fighting capability – – that expose what may end up being a viral Achilles’ heel,’ the news headlines service writes.At maturity, any remaining stability will be paid by the issuance of common shares at a cost of C$0.155 per share. 3SBio may also nominate one member to Isotechnika’s Panel of Directors. This agreement represents a significant milestone for the continued development of voclosporin in transplantation indication worldwide after Isotechnika regained global privileges of this item in 2008, commented Dr. Robert Foster, the elected president and CEO of Isotechnika. He continuing, 3SBio’s commercial knowledge and leading franchise in nephrology in China make the company a perfect partner for the spot and further validation of voclosporin’s market potential. We continue to look for strategic partnerships in various other regions.